Cyanocobalamin (vitamin b12) treatment in allergic disease

Details Cyanocobalamin (vitamin b12) treatment in allergic disease Cyanocobalamin (vitamin b12) treatment in allergic disease

A - Human Necessities

61

K

A61K 31/714 (2006.01) A61K 9/00 (2006.01) A61K 9/02 (2006.01) A61K 31/70 (2006.01) A61P 37/08 (2006.01)

Patent

CA 2358054

Vitamin B12 is administered to allergy patients via mucosal membranes in a series of lozenges and other patient friendly transmucosal modes of delivery given repeatedly over a period of time to reduce the symptoms and IgE antibodies associated with allergic diseases such as allergic rhinitis (hay fever), and allergic asthma.

L'invention concerne un traitement consistant à administrer de la vitamine B12 à des patients souffrant d'allergies, soit via les muqueuses sous la forme d'une série de pastilles, soit par d'autres modes d'administration via les muqueuse, non gênants pour le patient, de façon répétée et pendant une certaine période, en vue de réduire les symptômes et les anticorps IgE associés aux allergies, telles que la rhinite allergique (rhume des foins) et l'asthme allergique.

Affiliated with

Also associated with

Rating

Cyanocobalamin (vitamin b12) treatment in allergic disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyanocobalamin (vitamin b12) treatment in allergic disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyanocobalamin (vitamin b12) treatment in allergic disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2021096